Ap­plied Ther­a­peu­tics CEO steps down af­ter rare dis­ease drug re­jec­tion

Ap­plied Ther­a­peu­tics is mak­ing changes to its lead­er­ship less than a month af­ter the FDA re­ject­ed its rare dis­ease drug.

Shoshana Shen­del­man is step­ping down …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER